文献速递关节外科运动医学

单次关节内注射氨甲环酸对大鼠模型关节软骨和半月板的体内影响

In Vivo Effect of Single Intra-Articular Injection of Tranexamic Acid on Articular Cartilage and Meniscus: Study in a Rat Model.
PubMed 文献 · J Bone Joint Surg Am · 2023-11-28

研究利用大鼠前交叉韧带切断模型,单次关节内注射不同浓度氨甲环酸(0、20、50、100、150 mg/mL),评估其对软骨和半月板的细胞活性及组织学影响。结果显示50、100、150 mg/mL组软骨细胞活性显著降低,100和150 mg/mL组出现软骨和半月板退变,150 mg/mL组骨关节炎研究学会评分和半月板评分显著升高。作者认为应避免关节内注射≥100 mg/mL的氨甲环酸。

要点

  • 50、100、150 mg/mL氨甲环酸组软骨细胞活性较生理盐水组显著降低(p=0.001、p<0.001、p<0.001)。
  • 100和150 mg/mL组在8周时出现软骨和半月板退变,150 mg/mL组骨关节炎研究学会评分显著高于生理盐水组和20 mg/mL组(p=0.010和p=0.007)。
  • 作者认为应避免关节内注射≥100 mg/mL的氨甲环酸。

核心结论

  • 浓度≥100 mg/mL的氨甲环酸可导致大鼠软骨和半月板细胞活性降低,并引起前交叉韧带切断后显著的软骨退变。
  • 150 mg/mL氨甲环酸还导致显著的半月板退变。
  • 作者认为应避免关节内注射≥100 mg/mL的氨甲环酸。

研究设计与样本

  • 大鼠膝关节不稳模型,行前交叉韧带切断术后单次关节内注射氨甲环酸(0、20、50、100、150 mg/mL,溶于生理盐水)。
  • 细胞活性评估每组n=6,于24小时进行;大体观察和组织学分析于2、4、8周进行(每组每个时间点n=6)。

主要发现

  • 与生理盐水组相比,50、100、150 mg/mL氨甲环酸组软骨细胞活性显著降低(p=0.001、p<0.001、p<0.001),半月板细胞活性亦显著降低(p=0.042、p<0.001、p<0.001)。
  • 第8周时,生理盐水组、20和50 mg/mL组外观相对正常,而100和150 mg/mL组出现程度不一的软骨和半月板退变加重。
  • 150 mg/mL组平均骨关节炎研究学会评分显著高于生理盐水组和20 mg/mL组(p=0.010和p=0.007)。
  • 150 mg/mL组平均半月板评分显著高于生理盐水组、20 mg/mL组和50 mg/mL组(p=0.020、p=0.021、p=0.031)。

临床怎么用

  • 作者认为,应避免关节内注射浓度≥100 mg/mL的氨甲环酸,因该浓度可能对软骨和半月板产生不良影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) has been increasingly used in arthroscopic surgery to prevent hemarthrosis. Despite its effectiveness, safety concerns have been raised regarding its potential cytotoxicity to articular cartilage and meniscus following intra-articular injection. METHODS: To evaluate the impact of TXA on cartilage and meniscus, a rat model of knee instability was utilized wherein anterior cruciate ligament (ACL) transection surgery was followed by a single intra-articular injection of TXA at varying concentrations (0, 20, 50, 100, and 150 mg/mL) in saline solution. Cell viability assessment of the cartilage and meniscus (n = 6 per group) was conducted at 24 hours, and gross observation and histological analysis of the medial tibial plateau and medial meniscus were conducted at 2, 4, and 8 weeks (n = 6 per group and time point). RESULTS: The chondrocyte viability was significantly decreased in the 50, 100, and 150 mg/mL TXA groups compared with the specimens injected with saline solution only (saline group) (p = 0.001, p < 0.001, p < 0.001, respectively), as was meniscal cell viability (p = 0.042, p < 0.001, p < 0.001, respectively). At week 8, the saline and 20 and 50 mg/mL groups showed relatively normal appearances, whereas the 100 and 150 mg/mL groups exhibited increased and varying severity of cartilage and meniscal degeneration. In the 150 mg/mL group, the mean Osteoarthritis Research Society International score was significantly higher than that in the saline and 20 mg/mL groups (p = 0.010 and p = 0.007). Additionally, the mean meniscus score in the 150 mg/mL group was significantly higher than that in the saline, 20 mg/mL, and 50 mg/mL groups (p = 0.020, p = 0.021, p = 0.031, respectively). CONCLUSIONS: Our findings indicate that concentrations of TXA at or above 100 mg/mL can lead to decreased cell viability in both cartilage and meniscus, resulting in significant cartilage degeneration in rats with ACL transection. Furthermore, the use of 150 mg/mL of TXA led to significant meniscal degeneration. CLINICAL RELEVANCE: It is prudent to avoid using concentrations of TXA at or above 100 mg/mL for intra-articular injection, as such concentrations may result in adverse effects on the cartilage and meniscus.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Wang M, Li Y, Lin S, et al. In Vivo Effect of Single Intra-Articular Injection of Tranexamic Acid on Articular Cartilage and Meniscus: Study in a Rat Model. J Bone Joint Surg Am. 2023. PMID: 38015926. doi:10.2106/JBJS.23.00294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。